Introduction: Surgical resection is the treatment of choice for pancreatic ductal adenocarcinoma (PDA). However, in case of venous tumor involvement, carcinomas are classified as borderline resectable and their preferential therapy remains controversial. The purpose of this study is to analyze the effectiveness of the surgical approach with simultaneous venous resection regarding perioperative outcome and long-term survival. Patients and methods: All patients that underwent pancreatoduodenectomy (PD) for PDA at our institution between 02/2002 and 12/2016 were analyzed retrospectively. A matched-pair analysis between patients that underwent PD with simultaneous venous resection (PDVR) and standard PD was performed to compare perioperative parameters, survival and factors relevant to long-term survival. Results: The study included 142 patients: 71 underwent PDVR and 71 underwent standard PD. Venous tumor infiltration could histopathologically be confirmed in 21 patients (29.58%). PDVR wasn't associated with a higher rate of postoperative complications (56.34% for both groups), severe postoperative complications (28.17% vs. 23.94%) and mortality (5.63% vs. 9.86%) compared to standard PD. Median overall survival of both groups was 17 months (95% CI 10.89 -23.11), without statistical significance between the two groups (PD 22 months, 95% CI 16.02 -27.99 vs. PDVR 16 months, 95% CI 9.96 -22.04, p = 0.087). Parameters associated with overall survival were histopathologically proven venous tumor infiltration, the lymph node status and the necessity of postoperative blood transfusions. Conclusion: PDVR is justified, because peri-and post-operative morbidity and mortality, as well as long-term survival, are comparable to standard PD. Even in case of postoperatively histopathologically confirmed venous tumor infiltration, patients benefit over palliative treatment.
Introduction
Pancreatic ductal adenocarcinoma is the most common type of pancreatic cancer [1] . The mortality rate is roughly the same than its incidence [2] . Hence, pancreatic ductal adenocarcinoma is one of the most aggressive malignancies in the gastrointestinal system and the fourth leading cause of cancer related death [3] [4] . Surgery, especially the resection with microscopical negative margins (R0), is the treatment of choice and the strongest predictor for long-term survival [5] [6] [7] [8] .
Unfortunately, less than a quarter of all patients with pancreatic head cancer are suitable candidates for primary resection [9] , since the majority of patients suffer from locally advanced or metastatic disease at the time of diagnosis [10] .
Among the latter, there is a subgroup of patients with venous tumor involvement (superior mesenteric vein [SMV] or/and portal vein [PV]) on preoperative imaging. For these patients, the standard treatment is still in the discussion: besides surgical resection followed by chemotherapy, which is the standard care for primary resectable tumors and performed increasingly in high volume centers, palliative therapy and neoadjuvant chemotherapy are alternative therapeutic options [11] . There are various arguments in favor or against the therapeutic strategies mentioned previously. First, the differentiation between a vascular tumor infiltration on the one hand or a venous involvement by a peritumoral inflammation process on the other hand is hardly possible based on preoperative imaging [12] [13] . Second, it is still in debate if venous tumor infiltration is only a result of tumor location and tumor extension [12] [14] [15] or whether it is an indication for a particularly aggressive tumor biology [16] [17] [18] [19] . Furthermore, a preoperative chemotherapy might reduce tumor extent and improve the R0 resectability and survival in case of tumor response [14] [20] [21] , but if the tumor expands during the neoadjuvant therapy, patients lose their prospect of cure.
At the present day as well as in the near future, there is no and not likely will be a prospective randomized evaluation of venous resection within the whipple or the pylorus preserving whipple procedure, because it is hardly possible to discriminate between a direct tumor infiltration into the vein or only an inflammatory tumor adherence to the vessel, both on preoperative imaging and on intraoperative exploration. Furthermore, inter-surgeon variation in the interpretation of the adherence has to be taken into account with regard to the reliability of the results [22] . In addition, patients' consent to a trial that might waive tumor re- 
Patients and Methods
Clinicopathological characteristics of the patients were derived from our pan- Standard PD comprised the en bloc removal of the pancreatic head, the common bile duct, the gallbladder, the duodenum and the lymphadenectomy of the levels 1 and 2. The pylorus and the distal part of the stomach were only resected if there was a direct involvement by the tumor. The reconstruction was performed either by a pancreatogastrostomy or a side to side pancreaticojejunostomy, an end to side hepaticojejunostomy and a retrocolic or orthotopic end to side anastomosis between the post-pyloric duodenum or the stomach and the jejunum.
In case of tumor adherence or infiltration into the PV and/or SMV, a pancreatoduodenectomy with simultaneous venous resection (PDVR) was performed which means that the relevant segment of the vein had to be resected, too. Depending on the extent of tumor involvement, a wedge resection or the resection of the entire segment of the vein with primary anastomosis or interposition of a graft had to be performed. Preoperative information about tumor extension related to the SMV or/and PV was standardized taken from the preoperative CT scan.
In hospital mortality was defined as death before discharge from hospital. Data about patients overall survival were taken from patients' relatives, general practitioners, oncologists or from the cancer registry.
Pathological analysis included the size of the tumor itself (T1, tumor limited to the pancreas, ≤2 cm in greatest dimension; T2, tumor limited to the pancreas, >2 cm in greatest dimension; T3, tumor extends beyond the pancreas, but without involvement of the celiac axis or the superior mesenteric artery; T4, tumor involves the celiac axis or the superior mesenteric artery), the lymph node status (N0, no regional lymph node metastases; N1, regional lymph node metastases), the number of harvested and the number of positive lymph nodes, as well as lymphvascular and perineural infiltration, and the invasion of the SMV and/or PV in case of simultaneous resection. Furthermore, the residual tumor classification (R0, no residual tumor; R1, microscopic residual tumor; R2, macroscopic residual tumor) and the tumor grading (G1, well differentiated; G2, moderately differentiated; G3, poorly differentiated) were analyzed. This tumor grading classification is consistent to the seventh edition of the American Joint
Committee on Cancer staging system [24] .
In order to assess the impact of extended PD with simultaneous venous resection on morbidity and mortality, we built a matched-pair analysis, based on the type of surgery that was performed, between patients that underwent PDVR 
Results

Demographic Data
Within the For each of these 71 patients we found a matched patient that underwent standard PD after exclusion of a venous tumor involvement at the same period (group 2). There were no statistically significant differences between the two groups in terms of gender, age and ASA-Score (Table 1) .
None of the patients, neither in group 1 nor in group 2, had received a neoadjuvant therapy.
Tumor Characteristics
On final histopathological examination the majority of tumors were classified as Furthermore, statistical analysis revealed no significant differences between the two groups regarding the lymph vascular, perineural invasion or tumor grading. The rate of R0 resections was significantly higher in group 2 than in group 1 (71.83% vs. 53.52%, p = 0.024). Patients with histopathologically proven venous tumor infiltration had a higher incidence of R1 resections (61.90% vs. 38.10%, p = 0.156). In the postoperative course the overall complication rate was 56.34%, being equal for both groups. The incidence of major complications Clavien-Dindo ≥ 3 (PDVR 28.17% vs. PD 23.94%) as well as the rate of surgery associated complications (PDVR 42.25% vs. PD 45.07%) did not differ significantly between the two groups. Altogether 11 patients (7.75%) died within the hospital stay, 4 patients after PDVR (5.63%) and 7 patients after PD (9.86%), p = 0.346. Furthermore, there were no statistically significant differences between the PVDR and the PD group with regard to relevant postoperative pancreatic fistula, type B and C according to the definition of the ISGPF [23] 
Surgical Therapy and Peri-, Post-Operative Outcome
Survival Analysis
The median overall survival of both groups was 17 months (95% CI 10. Figure 3 and Figure 4 .
Other parameters with statistically significant influence on overall survival were a positive lymph nodes status on histopathological examination and the need for postoperative blood transfusions (Table 3) . Multivariate analysis did not reveal any parameters with significant influence on overall survival (Table 3 ).
Discussion
Pancreatic ductal adenocarcinoma rates among the most common cancer related causes of death [3] ). Neither today nor in the near future there will be any alternative curative therapy other than surgery. In fact, due to surgical as well as peri-, postoperative improvements and therefore decreasing peri-and postoperative morbidity and mortality [25] , surgery plays an increasingly important part in the therapy of pancreatic ductal adenocarcinoma and the resection indications could be extended [26] [27] [28] . The core objective of these advanced, more radical surgeries, including among others extended lymphadenectomy [29] , multivisceral resections [30] as well as synchronous arterial and venous resections, is to decrease the number of positive margins, a key prognostic factor The authors' analysis includes 71 patients that underwent PD with simultaneous venous resection at the time of (pp-) whipple procedure and another 71 patients with the same risk factors regarding age, gender and comorbidities that underwent standard PD.
As might be reasonably expected, most of the tumors were classified pT3 at final histopathological analysis and there was no statistically significant difference in their incidence between the two groups. In approximately one third of the specimen after PDVR, the tumor infiltration into the venous wall could histopathologically be confirmed. This finding underlines the difficulty to discriminate between real tumor infiltration or only peritumoral inflammatory involvement of the vessels, both on preoperative imaging and on the basis of the intraoperative macroscopic aspect [34] [35] . On final histopathological analysis the incidence of a positive lymph node status (pN1) was higher in the PDVR group than in the PD group, even though it did not reach statistical significance.
Further examination revealed that the number of harvested as well as the number of positive lymph nodes were significantly higher after PDVR compared to standard resection (p = 0.025 and p = 0.001).
The first aspect appears to be evident as the extended resection results in a larger number of harvested lymph nodes [34] . tration is associated with a higher incidence of R1 resection status (47.62%). This finding may be one of the reasons for the reduced overall survival of these patients [36] , as written below, and can be supported by former studies: Malleo et al. [34] report a significantly higher incidence of R1 resection status of 60.7% vs.
35.6%, if the tumor infiltration into the venous wall could be confirmed, maybe due to the close proximity of the tumor to the superior mesenteric artery neural plexus [13] .
Regarding the peri-and postoperative outcome, the present analysis shows that the PD with simultaneous venous resection is not chancier than the standard procedure and can be performed safely at high volume centers [37] According to the present analysis, the median operation time and the median estimated intraoperative blood loss were comparable between the two groups. In contrast, Zhou et al. report that PDVR is associated with both a significantly higher estimated blood loss and operation time [39] . Despite the similar median estimated blood loss, peri-and postoperative blood transfusions were significantly more common in patients after PDVR, as reported by Wang et al. [13] , too. One reason for this discrepancy may be that the venous resection might carry a higher risk for postoperative hemorrhage and therefore surgeons aim at a higher hemoglobin level in these patients in the early postoperative period.
The median overall survival of the 142 patients included in the study was 17 months (range 1 -144 months), which is comparable to the results of Roch et al. [44] . Patients that underwent PD tend to have a longer median survival than those with simultaneous venous resection, but without statistical significance.
In contrast, the median overall survival of patients with histopathologically proven tumor infiltration into the venous wall was significantly worse than the survival rate of those without venous tumor infiltration [11] (12 months, 95% CI 10.97 -13.34 vs. 19 months, 95 CI 13.67 -24.33; p = 0.048). As reported by Giovinazzo et al. [11] one reason for this finding may be the association between venous tumor infiltration and an increased rate of disease residual (R1), although the resection status (R0 vs. R1) does not reach statistical significance (p = 0.066) in the present univariate analysis. Instead the authors are able to show that the lymph node status, N0 vs. N1, has a significant influence on overall survival. This finding can be supported by further investigations according to which the venous tumor infiltration itself is proven to be an indication for a particular aggressive tumor biology that tends to early metastatic spread [16] [17] [18] [19] . Similarly, Delpero et al. [40] report that R1 resection status is frequently associated with nodal metastasis as well as increased lymph node ratio.
The present study also reveals the number of positive lymph nodes as prognostic factor for long-term survival that barely missed statistical significance (p = 0.07). Similar findings are reported by Banz et al. [45] who ascertained that patients with higher percentage of positive lymph nodes had a shorter survival independent of the vein resection status.
Another parameter that correlates significantly with overall survival on univariate analysis is the need for postoperative blood transfusions: On the one hand, they might be an indication for postoperative complications but, in the present analysis, the rate of postoperative complications in general as well as major complications, surgical associated or specific complications like reoperations, incidence of postoperative pancreatic fistula, bile fistula, postoperative bleeding have no significant influence on overall survival. On the other hand, the negative DOI: 10.4236/ss.2018.911045 394 Surgical Science impact of blood transfusions themselves on overall survival has been demonstrated well in the past [46] [47], although the underlying mechanisms remain mostly speculative [37] . There are some limitations of the study. It is a single center study and a retrospective analysis. Although it is one of the largest single center studies that have been reported, it is nevertheless a quite small group of patients and therefore the statistical power is limited. Another point is that the study does not provide information about the extent of venous resection, wedge resection or segmental resection, nor the prevalence of a postoperative chemotherapy.
Conclusion
With these limitations in mind, the present study demonstrates that PDVR is not associated with increased peri-and post-operative morbidity and mortality compared to standard PD and can be performed safely at high volume centers.
Furthermore, the authors support the oncologic tumor resection in case of preoperative or intraoperative signs of venous tumor involvement. First, as a remarkable percentage of tumors do not infiltrate the venous wall according to the final histopathological analysis, as could be shown by the authors, it is not justified to withhold these patients the chance of cure. Second, even in case of confirmed venous tumor infiltration on postoperatively histopathological analysis, patients benefit from a better overall survival compared to patients that receive only a palliative chemotherapy [48] or undergo palliative bypass surgery [49] .
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